Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 1Phase 2 Interventional Results available

Study in Participants With Early Stage Coronavirus Disease 2019 (COVID-19) to Evaluate the Safety, Efficacy, and Pharmacokinetics of Remdesivir Administered by Inhalation

ClinicalTrials.gov ID: NCT04539262

Public ClinicalTrials.gov record NCT04539262. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 22, 2026, 6:46 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 1b/2a Study in Participants With Early Stage COVID-19 to Evaluate the Safety, Efficacy, and Pharmacokinetics of Remdesivir Administered by Inhalation

Study identification

NCT ID
NCT04539262
Recruitment status
Completed
Study type
Interventional
Phase
Phase 1, Phase 2
Lead sponsor
Gilead Sciences
Industry
Enrollment
156 participants

Conditions and interventions

Conditions

Interventions

  • Remdesivir (RDV) Drug
  • Placebo Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Sep 13, 2020
Primary completion
Feb 25, 2021
Completion
Mar 21, 2021
Last update posted
Mar 2, 2022

2020 – 2021

United States locations

U.S. sites
28
U.S. states
8
U.S. cities
23
Facility City State ZIP Site status
The Institute for Liver Health Mesa Arizona 85210
The Institute for Liver Health Tucson Arizona 85712
Franco Felizarta, MD Bakersfield California 93301
Aurora FDRC Inc. Costa Mesa California 92627
Elevated Health Huntington Beach California 92648
Cedars-Sinai Medical Center Los Angeles California 90048
Western Clinical Research Placentia California 92870
UC Davis Health/Medical Center Sacramento California 95817
Bradenton Research Center, Inc. Bradenton Florida 34205
Integrity Clinical Research, LLC Doral Florida 33166
Holy Cross Hospital Fort Lauderdale Florida 33308
Research in Miami, Inc. Hialeah Florida 33013
Evolution Clinical Trials, Inc. Hialeah Gardens Florida 33016
Optimus U Corporation Miami Florida 33125
L & C Professional Medical Research Institute Miami Florida 33144
Westchester Research Center at Westchester General Hospital Miami Florida 33155
MedBio Trials Miami Florida 33180
Nuovida Research Center, Corp Miami Florida 33186
IMIC Inc Palmetto Bay Florida 33157
Triple O Research Institute, PA West Palm Beach Florida 33401
Family Care Research Boise Idaho 83704
CTU Covid Research Center New Orleans Louisiana 70112
STAT Research Vandalia Ohio 45066
Inquest Clinical Research Baytown Texas 77521
DFW Clinical Research Dallas Texas 75234
Baylor Research Institute Dallas Texas 75246
PCP for Life-Tidwell Houston Texas 77093
Providence Regional Medical Center Everett Everett Washington 98201

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT04539262, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Mar 2, 2022 · Synced Jul 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT04539262 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →